Cargando…

Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer

BACKGROUND: Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast cancer. Endocrine therapies targeting the estrogen receptor are effective in breast cancer, but their success is limited by intrinsic and acquired resistance. METHODOLOGY/PRINCIPAL FINDINGS: With the go...

Descripción completa

Detalles Bibliográficos
Autores principales:	Musgrove, Elizabeth A., Sergio, C. Marcelo, Loi, Sherene, Inman, Claire K., Anderson, Luke R., Alles, M. Chehani, Pinese, Mark, Caldon, C. Elizabeth, Schütte, Judith, Gardiner-Garden, Margaret, Ormandy, Christopher J., McArthur, Grant, Butt, Alison J., Sutherland, Robert L.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2496892/ https://www.ncbi.nlm.nih.gov/pubmed/18714337 http://dx.doi.org/10.1371/journal.pone.0002987

Ejemplares similares

Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup
por: Alles, M. Chehani, et al.
Publicado: (2009)

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome
por: Butt, Alison J, et al.
Publicado: (2008)

BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast
por: Millar, E K A, et al.
Publicado: (2009)

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection
por: Criscitiello, Carmen, et al.
Publicado: (2010)

Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
por: Caldon, C. Elizabeth
Publicado: (2014)

Live or let die: oestrogen regulation of survival signalling in endocrine response
por: Butt, Alison J, et al.
Publicado: (2007)

Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer
por: Caldon, C Elizabeth, et al.
Publicado: (2010)

Estrogen receptor degradation: a CUE for endocrine resistance?
por: Musgrove, Elizabeth A
Publicado: (2011)

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen
por: Loi, Sherene, et al.
Publicado: (2008)

ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
por: Kalyuga, Maria, et al.
Publicado: (2012)

Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen
por: Bordeaux, Jennifer M., et al.
Publicado: (2012)

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
por: Kang, Jian, et al.
Publicado: (2014)

Partial Inhibition of Estrogen-Induced Mammary Carcinogenesis in Rats by Tamoxifen: Balance between Oxidant Stress and Estrogen Responsiveness
por: Singh, Bhupendra, et al.
Publicado: (2011)

Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer
por: Bostner, Josefine, et al.
Publicado: (2017)

ATM suppresses c-Myc overexpression in the mammary epithelium in response to estrogen
por: Najnin, Rifat Ara, et al.
Publicado: (2023)

miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
por: HE, YUE-JUN, et al.
Publicado: (2013)

Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors
por: Kim, Hyunsoo, et al.
Publicado: (2023)

Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor–Positive Primary Human Breast Tumors
por: Kim, Hyunsoo, et al.
Publicado: (2023)

Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells
por: Cheng, Ran, et al.
Publicado: (2017)

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer
por: Loi, Sherene, et al.
Publicado: (2009)

A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen
por: Lebedeva, Galina, et al.
Publicado: (2012)

A Role for Estrogen Receptor Phosphorylation in the Resistance to Tamoxifen
por: de Leeuw, Renée, et al.
Publicado: (2011)

Tamoxifen non-estrogen receptor mediated molecular targets
por: Bogush, Tatiana, et al.
Publicado: (2012)

Tamoxifen-Induced Epigenetic Silencing of Oestrogen-Regulated Genes in Anti-Hormone Resistant Breast Cancer
por: Stone, Andrew, et al.
Publicado: (2012)

Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells
por: McCloy, R A, et al.
Publicado: (2013)

Liver hyperplasia after tamoxifen induction of Myc in a transgenic medaka model
por: Menescal, Luciana A., et al.
Publicado: (2012)

CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER(+ )disease
por: Sutherland, Robert L, et al.
Publicado: (2009)

Cyclin D1 and mammary carcinoma: new insights from transgenic mouse models
por: Sutherland, Robert L, et al.
Publicado: (2002)

Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells
por: Palaniappan, Murugesan, et al.
Publicado: (2018)

Tuning the MYC response
por: Zheng, Ying, et al.
Publicado: (2016)

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer
por: Gjerde, Jennifer, et al.
Publicado: (2010)

Estrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models
por: Zou, Wei, et al.
Publicado: (2015)

Estrogen Receptor Expression and Estrogen Receptor‐independent Cytotoxic Effects of Tamoxifen on Malignant Rhabdoid Tumor Cells in vitro
por: Koshida, Shigeki, et al.
Publicado: (2002)

PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2013)

Editorial: Proceedings From ACCM19: Cell Cycle, DNA Damage Response and Telomeres
por: Burgess, Andrew, et al.
Publicado: (2020)

OR26-2 Phosphorylation of Estrogen Receptor Alpha is Required for Mammary Gland Development and MCF-7 Breast Tumor Response to Estradiol and Tamoxifen
por: Emneser, Waleed, et al.
Publicado: (2019)

miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets
por: Klinge, Carolyn M.
Publicado: (2015)

Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice
por: Zhang, Zhi, et al.
Publicado: (2021)

Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
por: Peng, Wan-Xin, et al.
Publicado: (2021)

Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
por: Loi, Sherene, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_reu7gr5eq407uumtvjmjsrrr41